文献速递脑血管病认知障碍与痴呆

脑淀粉样血管病患者的记忆障碍与伴随tau病理相关

Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy.
PubMed 文献 · Neurology · 2021-02-24

这项横断面研究基于tau-PET成像,探讨 probable CAA 患者中记忆障碍是否与伴随的tau病理相关;结果显示遗忘型CAA患者海马体积更小、tau-PET结合更高,且tau-PET滞留和海马体积是记忆表现的独立预测因子。结论提示客观记忆障碍可作为潜在tau病理的标志。

要点

  • 遗忘型CAA患者较非遗忘型海马体积更小且tau-PET结合更高。
  • tau-PET滞留与海马体积是记忆表现的独立预测因子。
  • CAA患者客观记忆障碍可能提示潜在tau病理。

核心结论

  • probable CAA患者中客观记忆障碍的存在可能作为潜在tau病理的标志。

主要发现

  • 遗忘型CAA患者整体认知损害更重、海马体积更小(p < 0.001)、tau-PET结合更高(p = 0.003)。
  • 遗忘型与非遗忘型CAA患者在其他MRI标志物和淀粉样蛋白PET结合上无差异。
  • 广义线性模型中tau-PET滞留(β = -0.85, p = 0.001)和海马体积(β = 0.64, p = 0.01)是记忆表现的显著预测因子。
  • tau-PET滞留升高的CAA患者记忆域表现显著更低(p = 0.004)。

临床怎么用

  • 在probable CAA患者中评估客观记忆障碍,可提示进一步评估潜在tau病理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Relying on tau-PET imaging, this cross-sectional study explored whether memory impairment is linked to the presence of concomitant tau pathology in individuals with cerebral amyloid angiopathy (CAA). METHODS: Forty-six patients with probable CAA underwent a neuropsychological examination and an MRI for quantification of structural markers of cerebral small vessel disease. A subset of these participants also completed a [11C]-Pittsburgh compound B (n = 39) and [18F]-flortaucipir (n = 40) PET for in vivo estimation of amyloid and tau burden, respectively. Participants were classified as amnestic or nonamnestic on the basis of neuropsychological performance. Statistical analyses were performed to examine differences in cognition, structural markers of cerebral small vessel disease, and amyloid- and tau-PET retention between participants with amnestic and those with nonamnestic CAA. RESULTS: Patients with probable CAA with an amnestic presentation displayed a globally more severe profile of cognitive impairment, smaller hippocampal volume (p < 0.001), and increased tau-PET binding in regions susceptible to Alzheimer disease neurodegeneration (p = 0.003) compared to their nonamnestic counterparts. Amnestic and nonamnestic patients with CAA did not differ on any other MRI markers or on amyloid-PET binding. In a generalized linear model including all evaluated neuroimaging markers, tau-PET retention (β = -0.85, p = 0.001) and hippocampal volume (β = 0.64 p = 0.01) were the only significant predictors of memory performance. The cognitive profile of patients with CAA with an elevated tau-PET retention was distinctly characterized by a significantly lower performance on the memory domain (p = 0.004). CONCLUSIONS: These results suggest that the presence of objective memory impairment in patients with probable CAA could serve as a marker for underlying tau pathology. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that tau-PET retention is related to the presence of objective memory impairment in patients with CAA.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schoemaker D, Charidimou A, Zanon Zotin MC, et al. Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy. Neurology. 2021. PMID: 33627498. doi:10.1212/WNL.0000000000011745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。